Dennis Fitzpatrick, University of West London; Andrew Barton, Frimley Park Hospital, and Keith Pamment, City University, London, discuss a port location device that has been designed to improve first attempt port access, and to minimise the risk of subcutaneous infection and pain that a patient experiences with subsequent needle insertion attempts
Healthcare students all over the world use IV catheter inserters to study and practice the different...
Nurse’s play a critical role in the safe administration of intravenous (IV) anti-cancer therapy but ...
Direct-access, minimally invasive, beating-heart intracardial procedures have the potential to repla...
Implanted intravenous ports (IPs) are increasingly used in health care. The experience of having IPs...
The Portacator® is a class I medical device that efficiently locates and holds implanted Venous Acce...
Implanted ports are an important vascular access device for patients with malignancies requiring lon...
Chemoports are subcutaneously placed long term central venous access devices usually inserted under ...
Cancer itself is relatively hidden. Most cancers have a long incubation period. Chemotherapy drugs c...
In recent years an increasing incidence and prevalence of oncological diseases is observed, with a ...
Peripheral intravenous catheters (PIV) are frequently used in acute care settings for short-term del...
Phlebitis and cellulitis are commonly encountered problems in oncology Patients receiving chemothera...
The use of peripheral implanted ports to administer parenteral nutrition in a number of patient coho...
Central and peripheral venous catheters are used in>50 % of hospitalized patients, with>5 mill...
Purpose To evaluate the effectiveness of pre-procedural single-dose IV antibiotics during port place...
Patients were not proactively assessed for the proper vascular access device. Selection was reactive...
Healthcare students all over the world use IV catheter inserters to study and practice the different...
Nurse’s play a critical role in the safe administration of intravenous (IV) anti-cancer therapy but ...
Direct-access, minimally invasive, beating-heart intracardial procedures have the potential to repla...
Implanted intravenous ports (IPs) are increasingly used in health care. The experience of having IPs...
The Portacator® is a class I medical device that efficiently locates and holds implanted Venous Acce...
Implanted ports are an important vascular access device for patients with malignancies requiring lon...
Chemoports are subcutaneously placed long term central venous access devices usually inserted under ...
Cancer itself is relatively hidden. Most cancers have a long incubation period. Chemotherapy drugs c...
In recent years an increasing incidence and prevalence of oncological diseases is observed, with a ...
Peripheral intravenous catheters (PIV) are frequently used in acute care settings for short-term del...
Phlebitis and cellulitis are commonly encountered problems in oncology Patients receiving chemothera...
The use of peripheral implanted ports to administer parenteral nutrition in a number of patient coho...
Central and peripheral venous catheters are used in>50 % of hospitalized patients, with>5 mill...
Purpose To evaluate the effectiveness of pre-procedural single-dose IV antibiotics during port place...
Patients were not proactively assessed for the proper vascular access device. Selection was reactive...
Healthcare students all over the world use IV catheter inserters to study and practice the different...
Nurse’s play a critical role in the safe administration of intravenous (IV) anti-cancer therapy but ...
Direct-access, minimally invasive, beating-heart intracardial procedures have the potential to repla...